新型中毒死亡评分与改良早期预警评分预测急性中毒患者院内死亡的比较
本研究利用韩国疾病管理厅2019—2020年伤害监测队列数据,对新型中毒死亡评分进行外部验证,并与改良早期预警评分比较,共分析16,570例急性中毒患者。新型中毒死亡评分预测院内死亡的AUC为0.947,高于改良早期预警评分的0.800;灵敏度0.863 vs 0.667,特异度0.912 vs 0.817,准确率0.911 vs 0.814。校准曲线显示新型中毒死亡评分的预测死亡率与实际观察死亡率一致性更好。亚组分析中该评分系统表现持续稳定,尤其在高死亡指数物质中毒中表现突出。作者认为该评分有助于改善急诊临床决策和患者管理。
要点
- 在16,570例急性中毒患者中,新型中毒死亡评分预测院内死亡的AUC为0.947,改良早期预警评分为0.800。
- 新型中毒死亡评分灵敏度0.863、特异度0.912、准确率0.911,均高于改良早期预警评分的0.667、0.817、0.814。
- 校准曲线显示新型中毒死亡评分的预测死亡率与观察死亡率一致性更好。
- 亚组分析中新型中毒死亡评分表现持续稳定,尤其在高死亡指数物质中毒中表现突出。
- 作者认为该评分可用于急诊急性中毒患者的临床决策和患者管理。
适用人群与场景
- 2019—2020年韩国疾病管理厅伤害监测队列中的急性中毒患者,共16,570例,数据来自急诊科。
研究设计与关键结果
- 研究类型:回顾性分析,利用2019—2020年韩国疾病管理厅伤害监测队列数据进行外部验证。
- 研究人群:16,570例急性中毒患者。
- 主要终点:新型中毒死亡评分预测院内死亡的AUC为0.947,改良早期预警评分为0.800。
- 次要终点:新型中毒死亡评分灵敏度0.863 vs 改良早期预警评分0.667,特异度0.912 vs 0.817,准确率0.911 vs 0.814。
- 校准分析:采用Hosmer-Lemeshow拟合优度检验并生成校准曲线,新型中毒死亡评分的预测死亡率与观察死亡率一致性更好。
- 亚组分析:该评分系统表现持续稳定,尤其在高死亡指数物质中毒中表现突出,在所有物质组中均保持优势。
证据类型、等级与局限
- 证据类型:回顾性分析(外部验证研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,新型中毒死亡评分是预测急诊急性中毒患者院内死亡的有效工具,其多项指标优于改良早期预警评分。
- 作者认为,新型中毒死亡评分可有助于改善临床决策和患者管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The evaluation of acute poisoning is challenging due to varied toxic substances and clinical presentations. The new-Poisoning Mortality Score was recently developed to assess patients with acute poisoning and showed good performance in predicting in-hospital mortality. The objective of this study is to externally validate the performance of the new-Poisoning Mortality Score and to compare it with the Modified Early Warning Score.
METHODS: This retrospective analysis used data from the 2019-2020 Injury Surveillance Cohort, established by the Korea Center for Disease Control and Prevention, to perform external validation of the new-Poisoning Mortality Score. The statistical performances of the new-Poisoning Mortality and Modified Early Warning Scores were assessed and compared in terms of discrimination and calibration. Discrimination analysis involved metrics such as sensitivity, specificity, accuracy, and the area under the receiver operating characteristic curve. For calibration analysis, the Hosmer-Lemeshow goodness-of-fit test was utilized and calibration curves for each score were generated to elucidate the relationship between observed and predicted mortalities.
RESULTS: This study analysed 16,570 patients with acute poisoning. Significant differences were observed between survivors and those who died in-hospital, including age, sex, and vital signs. The new-Poisoning Mortality Score showed better performance over the Modified Early Warning Score in predicting in-hospital mortality, in terms of the area under the receiver operating characteristic curve (0.947 versus 0.800), sensitivity (0.863 versus 0.667), specificity (0.912 versus 0.817), and accuracy (0.911 versus 0.814). When evaluated through calibration curves, the new-Poisoning Mortality Score showed better concordance between predicted and observed mortalities. In subgroup analyses, the score system consistently showed strong performance, excelling particularly in substances with high mortality indices and remaining superior in all substances as a group.
CONCLUSIONS: Our study has helped to validate the new-Poisoning Mortality Score as an effective tool for predicting in-hospital mortality in patients with acute poisoning in the emergency department. The score system demonstrated superior performance over the Modified Early Warning Score in various metrics. Our findings suggest that the new-Poisoning Mortality Score can contribute to the enhancement of clinical decision-making and patient management.
参考来源
- Lee S, Kim SJ, Han KS, et al. Comparison of the new-Poisoning Mortality Score and the Modified Early Warning Score for predicting in-hospital mortality in patients with acute poisoning. Clin Toxicol (Phila). 2024. PMID: 38421362. doi:10.1080/15563650.2024.2310743
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。